
92% Booked
Antiviral Drug Development: Innovations and Applications is an intensive program designed to introduce participants to the dynamic field of antiviral research and pharmaceutical development. This program will cover fundamental virology, the mechanisms of viral entry and replication, and the current landscape of antiviral therapies including small molecule drugs, vaccines, and novel therapeutic strategies such as RNA interference and CRISPR-based treatments.
Antiviral Drug Development: Innovations and Applications is an intensive program designed to introduce participants to the dynamic field of antiviral research and pharmaceutical development. This program will cover fundamental virology, the mechanisms of viral entry and replication, and the current landscape of antiviral therapies including small molecule drugs, vaccines, and novel therapeutic strategies such as RNA interference and CRISPR-based treatments.
This program aims to equip participants with cutting-edge knowledge and practical skills necessary for the development and application of antiviral drugs. It focuses on the latest research, innovation in drug design, and the application of these drugs in managing and treating viral infections effectively.
PhD in Computational Mechanics from MIT with 15+ years of experience in Industrial AI. Former Lead Data Scientist at Tesla and current advisor to Fortune 500 manufacturing firms.
Professional Certification Program
Week 1: Virology and Drug Discovery Fundamentals
Viral replication cycles and molecular targets
Host-virus interactions and immune evasion mechanisms
Antiviral drug classifications and mechanisms of action
Historical milestones in antiviral therapeutics
Week 2: Drug Design Strategies and Screening Technologies
Rational drug design and structure-based approaches
High-throughput screening and compound libraries
In vitro antiviral assays and viral inhibition metrics
Computational modeling and AI-assisted drug prediction
Week 3: Therapeutic Innovation and Delivery Systems
Nucleoside analogues, protease inhibitors, and fusion blockers
Nanotechnology and targeted delivery platforms
Drug resistance and viral mutation management
Repurposing drugs for emerging viral infections
Week 4: Translational Research, Trials, and Regulatory Pathways
Clinical development pipeline and trial design
Regulatory compliance (FDA, EMA, CDSCO)
Emergency use authorization and pandemic preparedness
Future directions: mRNA antivirals, AI-driven formulation, global access
Students & Postgraduates in Virology, Pharmaceutical Sciences, Biotechnology, or Molecular Biology
PhD Scholars & Researchers involved in drug development, virology, or host-pathogen biology
Professionals in pharma R&D, biotech innovation, or regulatory affairs
Health Tech Entrepreneurs & Scientists exploring AI, nanotech, or bioinformatics in antiviral therapy
Standard Fee: INR 8,998 USD 198
Discounted Fee: INR 4499 USD 99
We are excited to announce that we now accept payments in over 20 global currencies, in addition to USD. Check out our list to see if your preferred currency is supported. Enjoy the convenience and flexibility of paying in your local currency!
List of Currencies
Take your research to the next level!
Achieve excellence and solidify your reputation among the elite!
Digital Twins: Predictive …
AI in Sound Modification
AI, Biopolymers, and Smart …
AI-Powered Drug Discovery with …
none
Instant Access
Not sure if this course is right for you? Schedule a free 15-minute consultation with our academic advisors.